Sun Pharma Q1 Result Tomorrow Key Expectations CNBC TV18

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=4zsPjAIgRnA

#4QWithCNBCTV18 | @SunPharma_Live to report #Q4FY23 earnings today. Growth to be driven by speciality biz while margin estimate is in the range of 24-26%. @ekta_batra lines up the expectations • Sun Pharmaceutical Industries is likely to post strong growth numbers for the quarter ended March 2023, largely driven by its specialty business, and robust sales in the domestic market. Some contribution from the sales of the generic of Revlimid, a drug used to treat multiple myeloma, in the US market will also aid growth. • #sunpharma #Q4FY23results #Q4FY23earnings #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettodaynews • • About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. • You can also connect with CNBC-TV18 News Online • Catch the latest news: https://bit.ly/2YbpXBM • Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/ • Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/ • You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/ • Subscribe to our Channel: https://bit.ly/3nvEcxf • Like us on Facebook: / cnbctv18india • Follow us on Twitter: / cnbctv18news • Follow us on Instagram: / cnbctv18india • Catch us on: Linkedin: / cnbc-tv18 • n18oc_business

#############################

New on site